We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our
Cookie Policy
.
Accept
Label
Search
SKIP TO CONTENT
SKIP NAVIGATION
Drug News
Trending
Commercial Operations
GMPs
FDA Enforcement Actions
Inspections and Audits
Postmarket Safety
Quality
Regulatory Affairs
Research and Development
Submissions and Approvals
FDAnews Drug Weekly
FDAnews
Device News
Trending
Commercial Operations
FDA Enforcement Actions
Inspections and Audits
Postmarket Safety
Quality
Regulatory Affairs
Research and Development
Submissions and Approvals
FDAnews Device Weekly
FDAnews
Books
FDAnews Books Library
Drug Books
Device Books
Training/Events
Webinar Training Pass
Events
Webinar Recordings
Resources
Form 483s Database
FDA Approved Drugs
CenterWatch
About Us
The Company
FDAnews Editorial Board
Contact Us
Advertising
Sign In
Create Account
Sign Out
My Account
Home
» FDA’s Overseas Offices Lack Device Experts
FDA’s Overseas Offices Lack Device Experts
August 28, 2009
While the FDA is beefing up its presence in other countries, many of its new overseas offices lack device facility inspection experts.
To View This Article:
Login
Email
Password
Register
Remember Me
Forgot your password?
Subscribe To Devices & Diagnostics Letter
Buy This Article Now
Add this article to your cart for $10.00
Upcoming Events
04
Apr
Managing Data and Documentation for FDA Inspections and Remote Assessments
11
Apr
Integrating Regulatory Intelligence into Supplier Management
14
Apr
MAGI 2024: The Clinical Research Conference
25
Apr
A Masterclass on Effective 483 Responses
14
May
2024 Avoca Quality Consortium Summit
Featured Products
FDA, FTC and DOJ Enforcement of Medical Device Regulations
Using Real-World Evidence in Drug and Device Submissions
Featured Stories
CDER Establishes New Quantitative Medicine Center of Excellence
Embracing, Expanding Sterilization Standards Endorsed in FDA Webinar
Six FDA Warning Letters Prompted by High Levels of Lidocaine in OTC Numbing Products
Comments on Benefit-Risk of Phthalates in Medical Devices Sought by EC
The Revised ICH E8:
A Guide to New Clinical Trial Requirements
Learn More